Table 2.

Descriptive statistics of the study variables

Measured variables	Mean score ± SD/Median (min–max)
PAM (0–100)*	67.29 ± 13.67
IPAQ (METS-min/week)	1876.74 ± 2127.04
NMSQ (0–30)	10.66 ± 5.45
LEDD (mg/day)	763.86 ± 573.01
MDS-UPDRS motor part (0–132)	31 (1–94)
FAI (0–45)	25.61 ± 10.36
10-MWT (m/sec)	0.99 ± 0.26
PDQ cognitions (0–100)	26.89 ± 21.23
PDQ emotions (0–100)	25.98 ± 24.84

PAM, Patient Activation Measure; IPAQ, International Physical Activity Questionnaire; NMSQ, Non-Motor Symptoms Questionnaire; LEDD, Levodopa Equivalent Dose; MDS-UPDRS, Movement Disorders Society-Unified Parkinson’s disease rating scale; FAI, Frenchay Activities Index; 10-MWT, 10 Meter Walk Test; PDQ cognitions, Parkinson Disease Questionnaire, cognitions; PDQ emotions, Parkinson Disease Questionnaire, emotional well-being

*Numbers in parentheses for the PAM, NMSQ, MDS-UPDRS motor part, FAI, and PDQ indicate the range of scores for each of these assessments